Radiation 'Re-Priming' may rescue failing CAR-T treatments
NCT ID NCT04601831
Summary
This study tested whether adding targeted radiation could help patients with aggressive lymphoma who didn't fully respond to CAR-T cell therapy. Researchers gave radiation to the remaining cancer spots in 14 patients about a month after their CAR-T treatment. They wanted to see if this 're-priming' approach was safe and could turn partial responses into complete remissions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.